SDGR - Schrodinger Inc-United States Stock Price, Fair Value and News

$20.57+0.20 (+0.98%)

Delayed as of 22 Nov 2024, 11:01 am ET

Max Portfolio Pct.

Check

Valuation

Check

Stock Quality:

Max Portfolio Pct.

Check

Valuation

Check

SDGR Price Action

Last 7 days

-0.1%

Last 30 days

8.9%

Last 90 days

2.4%

Trailing 12 Months

-33.7%

SDGR RSI Chart

SDGR Valuation

Market Cap

1.5B

Price/Earnings (Trailing)

-8.35

Price/Sales (Trailing)

7.67

EV/EBITDA

-7.62

Price/Free Cashflow

-8.6

SDGR Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

SDGR Fundamentals

SDGR Revenue

Revenue (TTM)

193.3M

Rev. Growth (Yr)

-17.1%

Rev. Growth (Qtr)

-25.44%

SDGR Earnings

Earnings (TTM)

-177.6M

Earnings Growth (Yr)

38.51%

Earnings Growth (Qtr)

29.44%

SDGR Profitability

Operating Margin

64.91%

EBT Margin

-92.05%

Return on Equity

-39.51%

Return on Assets

-26.53%

Free Cashflow Yield

-11.63%

SDGR Investor Care

Shares Dilution (1Y)

1.58%

Diluted EPS (TTM)

-2.43

Revenue & Growth

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2024	188.5M	200.6M	193.3M	0
2023	197.1M	193.8M	199.4M	216.7M
2022	154.5M	163.2M	170.3M	181.0M
2021	114.0M	120.7M	124.8M	137.9M
2020	91.0M	95.1M	100.9M	108.1M
2019	0	0	0	85.5M

Get all data in R, Python etc through our Historical Stock Data APIs

About Schrodinger Inc-United States

SchrÃƒÆ’Ã‚Â¶dinger, Inc., together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment is focused on licensing its software to transform molecular discovery for life sciences and materials science industries. The Drug Discovery segment focuses on building a portfolio of preclinical and clinical programs, internally and through collaborations. The company serves biopharmaceutical and industrial companies, academic institutions, and government laboratories worldwide. SchrÃƒÆ’Ã‚Â¶dinger, Inc. was incorporated in 1990 and is based in New York, New York.

CEO	Dr. Ramy Farid Ph.D.
WEBSITE	schrodinger.com
SECTOR	Healthcare
INDUSTRY	Health Information Services
EMPLOYEES	787

Schrodinger Inc-United States Frequently Asked Questions

What is the ticker symbol for Schrodinger Inc-United States? What does SDGR stand for in stocks?

SDGR is the stock ticker symbol of Schrodinger Inc-United States. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Schrodinger Inc-United States (SDGR)?

As of Thu Nov 21 2024, market cap of Schrodinger Inc-United States is 1.48 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of SDGR stock?

You can check SDGR's fair value in chart for subscribers.

Is Schrodinger Inc-United States a good stock to buy?

The fair value guage provides a quick view whether SDGR is over valued or under valued. Whether Schrodinger Inc-United States is cheap or expensive depends on the assumptions which impact Schrodinger Inc-United States's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for SDGR.

What is Schrodinger Inc-United States's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Thu Nov 21 2024, SDGR's PE ratio (Price to Earnings) is -8.35 and Price to Sales (PS) ratio is 7.67. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. SDGR PE ratio will change depending on the future growth rate expectations of investors.